Abstract
BackgroundUninterrupted direct oral anticoagulation (DOAC) in AF‐ablation is recommended, proven by randomized trials. The outcome and the periinterventional differences between DOACs and VKA in the real world clinical practice are discussed controversial.HypothesisTo investigate efficiency and safety of uninterrupted DOAC therapy compared to VKA during AF‐Ablation in real world setting with a focus on periinterventional heparin dosage.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
